C Baudouin - System, 1927 - interscience.wiley.com Antiglaucoma medications are often associated with ocular adverse reactions such
as dry eye, and burning or stinging sensations. These undesirable effects may
lead to treatment discontinuation and reduced quality of life in patients ... Cited by 7 - Related articles - All 2 versions
P Pellinen, J Lokkila - Ophthalmic Research, 2009 - content.karger.com Background: Some studies have shown that benzalkonium chloride (BAK), a
preservative used in antiglaucoma medications, can increase corneal permeability
by acting as a penetration enhancer. Tafluprost is a new prostaglandin F 2 ... Cited by 3 - Related articles - All 4 versions
C Baudouin - Cornea, 2009 - journals.lww.com Rationale: Dry eye and other symptoms of ocular surface disease are frequently
encountered in patients with glaucoma and ocular hypertension and associated
with the use of preserved topical anti- glaucoma medications. The most ... Related articles